A detailed history of Cibc Asset Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Cibc Asset Management Inc holds 1,533 shares of UTHR stock, worth $553,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,533
Previous 1,538 0.33%
Holding current value
$553,213
Previous $489,000 12.27%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$311.04 - $363.55 $1,555 - $1,817
-5 Reduced 0.33%
1,533 $549,000
Q2 2024

Aug 01, 2024

BUY
$228.26 - $319.04 $53,412 - $74,655
234 Added 17.94%
1,538 $489,000
Q3 2023

Oct 30, 2023

SELL
$211.82 - $248.24 $1,482 - $1,737
-7 Reduced 0.53%
1,304 $294,000
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $1,436 - $1,630
7 Added 0.54%
1,311 $289,000
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $28,114 - $36,454
132 Added 11.26%
1,304 $292,000
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $117,803 - $160,405
-572 Reduced 32.8%
1,172 $325,000
Q2 2022

Aug 09, 2022

SELL
$174.81 - $241.14 $22,200 - $30,624
-127 Reduced 6.79%
1,744 $411,000
Q4 2021

Feb 08, 2022

BUY
$184.32 - $216.08 $10,137 - $11,884
55 Added 3.03%
1,871 $404,000
Q3 2021

Nov 09, 2021

BUY
$179.86 - $214.88 $26,259 - $31,372
146 Added 8.74%
1,816 $335,000
Q1 2021

May 14, 2021

BUY
$153.94 - $174.85 $3,540 - $4,021
23 Added 1.4%
1,670 $279,000
Q4 2020

Feb 03, 2021

BUY
$101.87 - $151.79 $167,779 - $249,998
1,647 New
1,647 $250,000
Q1 2018

Apr 30, 2018

SELL
$107.21 - $151.94 $159,742 - $226,390
-1,490 Closed
0 $0
Q4 2017

Feb 02, 2018

BUY
$118.58 - $151.28 $176,684 - $225,407
1,490
1,490 $220,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.